Drag a card by its title · ⚙ to size, swap or remove

The company

MeiraGTx Holdings plc -

MGTX · Nasdaq

Health CareBiotechnologyNot moving yetSynthetic Biology / TechBio

MGTX stood above a rising 150-day average in 36 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 16.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 3
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $8.2M
Officials’ trades on record: 0
Institutions holding: 154 (+28)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 36 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months9

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Stuart NaylorCHIEF SCI OFCR, OPHTHALMOLOGY	sold	27,659at $10.64	6 Oct 2026filed 6 Oct 2026
Alexandria ForbesPRESIDENT & CEO	sold	62,000at $13.86	18 Aug 2026filed 18 Aug 2026
Richard GirouxCFO & COO	sold	56,000at $12.51	21 Jul 2026filed 21 Jul 2026
Stuart NaylorCHIEF SCI OFCR, OPHTHALMOLOGY	sold	2,547at $13.86	7 Jul 2026filed 7 Jul 2026
Stuart NaylorCHIEF SCI OFCR, OPHTHALMOLOGY	sold	25,112at $14.90	7 Jul 2026filed 7 Jul 2026
Alexandria ForbesPRESIDENT & CEO	sold	62,000at $9.17	19 May 2026filed 19 May 2026
Richard GirouxCFO & COO	sold	56,000at $10.22	21 Apr 2026filed 21 Apr 2026
Stuart NaylorCHIEF DEV. OFFICER	sold	27,661at $9.36	7 Apr 2026filed 7 Apr 2026
Alexandria ForbesPRESIDENT & CEO	sold	62,000at $7.41	24 Mar 2026filed 24 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders154+28 on the quarter

New · exited40 · 12

Reported value$1.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Sanofiunchanged · filed 28 Jul 2026	12,197,737$164.8M	00.0%
PERCEPTIVE ADVISORS LLCadded · filed 14 Aug 2026	10,786,658$145.7M	+460,555+4.5%
Rubric Capital Management LPadded · filed 14 Aug 2026	9,100,000$122.9M	+2,100,000+30.0%
JOHNSON & JOHNSONunchanged · filed 6 Aug 2026	6,641,064$89.7M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	4,757,178$64.3M	+1,589,030+50.2%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	4,400,000$59.4M	+400,000+10.0%
Opaleye Management Inc.added · filed 14 Aug 2026	3,550,000$48.0M	+1,426,741+67.2%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026	2,971,752$40.1M	-493,947−14.3%
683 Capital Management, LLCreduced · filed 14 Aug 2026	2,300,000$31.1M	-150,000−6.1%
Woodline Partners LPadded · filed 14 Aug 2026	1,500,135$20.3M	+1,199,812+399.5%